Skip to content
A–Z REFERENCE

Peptide research chart.

A navigable index of compounds, vial labels and evidence categories. Open the full page before interpreting a schedule or formulation calculation.

Showing 60 research entries

Swipe the chart sideways to see evidence and references →

CompoundVial labelTypeEvidence contextReference
5-Amino-1MQ50 mgSingleResearch summary · not a validated human regimenOpen
Adamax10 mgSingleResearch summary · not a validated human regimenOpen
Adipotide10 mgSingleResearch summary · not a validated human regimenOpen
AICAR50 mgSingleResearch summary · not a validated human regimenOpen
AOD-960410 mgSingle10 mg research vial · no validated preparation or dosing for supplier productsOpen
ARA-29010 mgSingleResearch summary · not a validated human regimenOpen
BPC-15710 mgSingleResearch summary · not a validated human regimenOpen
Cagrilintide5 mgSingleInvestigational · published phase 2 dose-finding studyOpen
Cartalax20 mgSingleResearch summary · not a validated human regimenOpen
CJC-1295 DAC5 mgSingleResearch summary · not a validated human regimenOpen
CJC-1295 No DAC10 mgSingleResearch summary · not a validated human regimenOpen
DSIP10 mgSingleResearch summary · not a validated human regimenOpen
Epithalon10 mgSingleResearch summary · not a validated human regimenOpen
FOXO4-DRI10 mgSingleResearch summary · not a validated human regimenOpen
GHK-Cu50 mgSingleResearch summary · not a validated human regimenOpen
GHRP-25 mgSingleResearch summary · not a validated human regimenOpen
GHRP-610 mgSingleResearch summary · not a validated human regimenOpen
Glow Stack70 mgBlendResearch summary · not a validated human regimenOpen
Glutathione600 mgSingleResearch summary · not a validated human regimenOpen
Gonadorelin2 mgSingleResearch summary · not a validated human regimenOpen
HCG5000 IUSingleResearch summary · not a validated human regimenOpen
HGH 191AA12 IU/vial · 120 IU kitAlso 32 IU/vial · 320 IU kitSingleIU-labelled research kits · 12 or 32 IU per vial; no validated human kit regimenOpen
IGF-1 LR31 mgSingleExperimental analogue · cell and animal evidence; no verified human regimenOpen
Ipamorelin10 mgSingleResearch summary · not a validated human regimenOpen
Kisspeptin10 mgSingleResearch summary · not a validated human regimenOpen
KLOW Blend80 mgBlendResearch summary · not a validated human regimenOpen
KPV10 mgSingleResearch summary · not a validated human regimenOpen
L-Carnitine200 mgSingleResearch summary · not a validated human regimenOpen
Livagen20 mgSingleResearch summary · not a validated human regimenOpen
LL-375 mgSingleResearch summary · not a validated human regimenOpen
Mazdutide10 mgSingleResearch summary · not a validated human regimenOpen
Melanotan II10 mgSingleResearch summary · not a validated human regimenOpen
MGF5 mgSingleResearch summary · not a validated human regimenOpen
MK-67725 mgSingleResearch summary · not a validated human regimenOpen
MOTS-C10 mgAlso 20 mg vialSinglePreclinical research · no validated human research-vial regimenOpen
Muscle Blend10 mgBlendResearch blend · no validated combined human regimenOpen
NAD+1000 mgSingleResearch summary · not a validated human regimenOpen
Oxytocin10 mgSingleResearch summary · not a validated human regimenOpen
PE-22-2810 mgSingleResearch summary · not a validated human regimenOpen
PEG-MGF2 mgSingleResearch summary · not a validated human regimenOpen
Pinealon20 mgSingleResearch summary · not a validated human regimenOpen
PNC-2710 mgSinglePreclinical research · no validated human research-vial regimenOpen
PT-14110 mgSingleResearch summary · not a validated human regimenOpen
Retatrutide10 mgAlso 20 mg vialSingleInvestigational · published human trialOpen
Selank10 mgSingleResearch summary · not a validated human regimenOpen
Semaglutide5 mgSingleApproved medicine · formulation-specific labelOpen
Semax10 mgSingleResearch summary · not a validated human regimenOpen
Sermorelin10 mgSingleResearch summary · not a validated human regimenOpen
Shred Stack55 mgBlendResearch summary · not a validated human regimenOpen
SLU-PP-3325 mgSinglePreclinical small molecule · no established human administration routeOpen
SS-3110 mgSingleResearch summary · not a validated human regimenOpen
Survodutide10 mgSingleResearch summary · not a validated human regimenOpen
TB-50010 mgSingleResearch summary · not a validated human regimenOpen
Tesamorelin10 mgSingleResearch summary · not a validated human regimenOpen
Testagen20 mgSingleResearch summary · not a validated human regimenOpen
Thymosin Alpha-110 mgSingleResearch summary · not a validated human regimenOpen
Tirzepatide10 mgSingleApproved medicine · label context differs from research vialsOpen
Vesugen20 mgSingleResearch summary · not a validated human regimenOpen
Vilon20 mgSingleResearch summary · not a validated human regimenOpen
Wolverine Stack10 mgBlendResearch summary · not a validated human regimenOpen

How to interpret this chart

The vial label describes nominal content, not a dose. Trial schedules are not individual instructions, and research-only vials are not licensed products. Any preparation must follow the exact formulation's validated instructions. Use the calculator for arithmetic after verifying the inputs.